Ipsen

Ipsen appoints Aidan Murphy as EVP, technical operations

He is promoted from senior VP biologics development and manufacturing. Ipsen has added to its executive leadership team in the form of Aidan Murphy, who becomes the biopharma’s executive vice ... Murphy, who has more than 25 years of industry experience

Ipsen promotes Alexis Vandier as general manager, France

Paris-based biopharmaceutical group Ipsen has appointed Alexis Vandier as its new general manager for the France region. ... Reporting to Ipsen’s executive vice president, Harout Semerjian, Vandier will also become a member of the company's global

Ipsen’s liver cancer treatment clears phase III trial

Cabometyx on track for new liver cancer indication. Ipsen and partner Exelixis are on track to file cancer treatment Cabometyx (cabozantinib) for a new liver cancer indication in the first half ... Ipsen will now “evaluate potential next steps in the

Ian Weatherhead joins Ipsen

Takes up corporate communications role at the French pharma firm. French biopharmaceutical company Ipsen has appointed Ian Weatherhead as vice president, corporate external communications. ... In his new role at Ipsen Weatherhead will be responsible for

CHMP backs three immuno-oncology drugs for solid tumours

Advanced Accelerator Applications secured a recommendation for Lutathera (lutetium [177Lu] oxodotreotide) - for the treatment of gastro-entero-pancreatic neuroendocrine tumours - and Ipsen got the nod for Xermelo (telotristat ethyl) as a

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]